NAM
GSK icon

NorthCrest Asset Manangement’s GSK GSK Stock Holding History

NorthCrest Asset Manangement’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,986
Closed -$226K – 948
2026
Q1 		$226K Sell
3,986
-1,192
-23% -$64.6K 0.01% 694
2025
Q4 		$254K Buy
5,178
+258
+5% +$12K 0.01% 723
2025
Q3 		$214K Sell
4,920
-341
-6% -$13.3K 0.01% 703
2025
Q2 		$201K Buy
+5,261
New +$201K 0.01% 606
2025
Q1 		– Sell
-7,392
Closed -$250K – 606
2024
Q4 		$250K Sell
7,392
-376,196
-98% -$13.5M 0.01% 515
2024
Q3 		$15.7M Buy
383,588
+1,491
+0.4% +$61K 0.47% 68
2024
Q2 		$14.7M Buy
382,097
+3,665
+1% +$154K 0.49% 63
2024
Q1 		$16.2M Buy
378,432
+8,879
+2% +$366K 0.55% 59
2023
Q4 		$13.7M Sell
369,553
-6,340
-2% -$228K 0.52% 64
2023
Q3 		$13.6M Buy
375,893
+8,389
+2% +$298K 0.56% 60
2023
Q2 		$13.1M Buy
367,504
+2,015
+0.6% +$72.3K 0.52% 64
2023
Q1 		$13M Buy
365,489
+40,973
+13% +$1.43M 0.54% 65
2022
Q4 		$11.4M Buy
324,516
+24,744
+8% +$824K 0.65% 53
2022
Q3 		$8.82M Buy
299,772
+1,240
+0.4% +$47K 0.48% 76
2022
Q2 		$16.2M Buy
298,532
+11,236
+4% +$620K 0.83% 33
2022
Q1 		$15.6M Buy
+287,296
New +$15.6M 0.74% 49

Other funds holding GSK

DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
BB
Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return
KIC
Keating Investment Counselors Delray Beach, Florida $364M AUM 22.11% 1-Year Est. Return
GHAM
Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return
AWAG
ARS Wealth Advisors Group St. Petersburg, Florida $1.28B AUM 24.51% 1-Year Est. Return
HAI
Hennessy Advisors Inc Novato, California $3.13B AUM 77.26% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

NorthCrest Asset Manangement's GSK Position: Q2 2026 in Review

NorthCrest Asset Manangement sold out of GSK (GSK) in Q2 2026, closing a stake of 3,986 shares — an estimated $226K sold.

NorthCrest Asset Manangement first reported a position in GSK in Q1 2022 and held it in 16 quarters. The position peaked at $16.2M in Q2 2022. 159 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • NorthCrest Asset Manangement reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
  • NorthCrest Asset Manangement sold 3,986 GSK shares in Q2 2026, an estimated $226K.
  • NorthCrest Asset Manangement first reported a position in GSK in Q1 2022 and held it in 16 quarters.
  • NorthCrest Asset Manangement's GSK position peaked at $16.2M in Q2 2022.
  • 159 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.